batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Avenzo's second trip to China 18 November 2024 Another makeover for Halozyme? 15 November 2024 Not so fast for Astra in bladder cancer 14 November 2024 The end looms for Syros 13 November 2024 A second sarcoma success for Adaptimmune 13 November 2024 Merck KGaA gets a rare cancer win 12 November 2024 Astra shifts its dato lung focus again 12 November 2024 Ideaya pushes on with a dual ADC approach 11 November 2024 Load More